JapanPart of Teijinteijin-pharma.co.jp
Teijin Pharma Limited is the healthcare subsidiary of the Teijin Group, a Japan-based materials and life-science company. Headquartered in Japan, Teijin Pharma engages in the research, development, manufacturing, and marketing of prescription pharmaceuticals and medical devices, and operates a large home healthcare service network. Its Japanese name is テイジンファーマ株式会社.
The company’s core areas include respiratory medicine (such as home oxygen therapy and noninvasive ventilation for chronic respiratory diseases), bone and joint disorders including osteoporosis, cardiovascular and metabolic diseases, and selected central nervous system and specialty indications. Teijin Pharma supports clinical development and post-market services and distributes its products and home healthcare solutions primarily in Japan, complemented by collaborations and licensing partnerships in other markets.
Also known as テイジンファーマ株式会社.
Japan expands XEOMIN label to two focal dystonias, adding to existing spasticity and sialorrhea indications.